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ABSTRACT 
SERPINS comprise a large and functionally diverse family of serine protease inhibi-
tors. Here, we report three unrelated families with loss-of-function mutations in SER-
PINB8 in association with an autosomal recessive form of exfoliative ichthyosis.  
Whole exome sequencing of affected individuals from a consanguineous Tunisian 
family and a large Israeli family revealed a homozygous frameshift mutation, 
c.947delA; p.Lys316Serfs*90, and a nonsense mutation, c.850C>T, p.Arg284*, re-
spectively. These two mutations are located in the last exon of SERPINB8 and, 
hence, would not be expected to lead to nonsense-mediated decay of the mRNA, 
nonetheless, both mutations are predicted to lead to loss of the reactive site loop of 
SERPINB8, which is crucial for forming the SERPINB8-protease complex. Using 
Sanger sequencing, a homozygous missense mutation, c.2T>C; p.Met1?, predicted 
to result in an N-terminal truncated protein, was identified in an additional family from 
UAE. Histological analysis of a skin biopsy from an individual homozygous for the 
variant p.Arg284* showed disadhesion of keratinocytes in the lower epidermal layers 
plus decreased SERPINB8 levels compared to control. In vitro studies utilizing siR-
NA-mediated knockdown of SERPINB8 in keratinocytes demonstrated that in the 
absence of the protein, there is a cell-cell adhesion defect, particularly when cells are 
subjected to mechanical stress. In addition, immunoblotting and immunostaining re-
vealed an upregulation of desmosomal proteins. In conclusion, we report mutations 
in SERPINB8 that are associated with exfoliative ichthyosis and provide evidence 
that SERPINB8 contributes to the mechanical stability of intercellular adhesions in 
the epidermis. 
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REPORT  
Rare genodermatoses with underlying mutations in genes encoding for proteases 
and protease inhibitors demonstrate that a dynamic balance between the activities of 
proteases and their inhibitors is indispensable for maintaining epidermal homeosta-
sis.1; 2 One such class of inhibitors is the SERPIN family of serine peptidase inhibi-
tors. Mutations in SERPINB7 (MIM: 603357) were identified in individuals with Na-
gashima-type palmoplantar keratosis (MIM: 615598)3; 4 and genome wide associa-
tion studies have linked the SERPINB8 (MIM: 601697) locus with psoriasis.5 Fur-
thermore, SERPINB3 (MIM: 600517), SERPINB4 (MIM: 600518), and SERPINB13 
(MIM: 604445) have also been recently linked to psoriasis (MIM: 177900) and atopic 
eczema (MIM: 605803) using transcriptomic and proteomic approaches.1 Serine pro-
tease cascades appear to be involved in various processes that are essential for ep-
idermal differentiation, such as lipid barrier formation and assembly of the cornified 
envelope.6 In this study, we report three families with putative loss-of-function muta-
tions in the serpin peptidase inhibitor, clade B, member 8, SERPINB8, linked to au-
tosomal recessive exfoliative ichthyosis. In vivo and in vitro studies demonstrate that 
loss of SERPINB8 impairs keratinocyte mechanical stability.  
Family one was from Tunisia and a history of parental relatedness was present.  The 
index individual , a five-year-old boy, suffered since he was three months old from 
superficial peeling of small areas of his palmar and dorsal faces of his hands and 
feet, painless and easily removed, with an underlying erythema. The symptoms were 
aggravated by heat, humidity and frictions (Figure 1A). His three-year old sister had 
the same symptomatology.  
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An additional individual from a second family from the United Arab Emirates was as-
certained. She presented with a similar clinical phenotype as the two affected indi-
viduals of family one but peeling was also present on her lower arms (Figure 1B). 
The third family enrolled in this study originated from Israel and was of Jewish Ash-
kenazi extraction. All three affected individuals presented with a more severe peeling 
compared to the affected individuals of families one and two. Age of onset was be-
tween four and six months. Clinical examination revealed superficial white scale with 
no significant erythema over their lower extremities and diffuse yellowish hyperkera-
totic plaques over the palms and soles (Figures 1C, 1D, 1E). In contrast to individu-
als with Nagashima-type palmoplantar keratosis caused by mutations in SERPINB7, 
no whitish change upon water exposure was observed on hyperkeratotic palms of 
affected individuals of family three. Of note, the maternal grandfather and his sister 
were affected by psoriasis.  
After obtaining written informed consent, genomic DNA was extracted from EDTA-
blood samples from all affected individuals and available family members. The pro-
ject was approved by the East London and City Health Authority Research Ethics 
Committee and was conducted according to the Declaration of Helsinki Principles. 
Initially, high-resolution homozygosity mapping was performed by genotyping both 
affected individuals, II-2 and II-5, of family one using the Affymetrix GeneChip Hu-
man Mapping 250K Nsp SNP array. Analysis was performed as described7 and a 
large block of 98.6% homozygosity shared by both siblings was identified on chro-
mosome 18 between rs1944983 and rs2194631, which contains several SERPIN 
genes. Subsequently, DNA samples from both affected siblings of family one were 
subjected to whole exome sequencing. Genomic DNA was extracted from EDTA 
blood using the QiAmp DNA Mini Kit (Qiagen). Exome sequencing was performed 
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using 3 µg of genomic DNA. Exome capture and enrichment was performed using 
the NimbleGen SeqCap EZ Library protocol (Roche Nimblegen). The subsequent 
DNA library was sequenced on an Illumina HiSeq2000. Variants were filtered against 
dbSNP137, the 1000 Genomes Project, and HapMap8, as described previously.8 
Given the parental relatedness of family one, we assumed that the peeling skin dis-
order is inherited in an autosomal recessive manner and the underlying gene muta-
tion was expected to be homozygous in the two siblings. In a region of homozygosity 
located on chromosome 18, the frameshift mutation in SERPINB8, exon 7: 
c.947delA; p.Lys316Serfs*90 was identified in both individuals and confirmed by 
Sanger sequencing (Figure 1F). The mother was heterozygous for the deletion. No 
DNA was available from the father. Unaffected siblings were either heterozygous for 
the frameshift variant or wildtype, supporting an autosomal-recessive mode of dis-
ease transmission. The deletion mutation is located a few base pairs upstream of the 
sequence that encodes for the reactive site loop (Figure 1H), which is crucial for 
binding of SERPINB8 to its target protease.9; 10 As the deletion is located in exon 7, 
the last exon, of SERPINB8 and leads to a frameshift, we predict that the transcript 
will not be subjected to nonsense-mediated mRNA decay, but rather the mutation 
results in a C-terminally extended SERPINB8 peptide that lacks the reactive site 
loop. The frameshift variant was also disclosed in a homozygous state in two individ-
uals and in a heterozygous state in six individuals of the putative healthy control 
population with a minor allele frequency of 0.079% (Exome Variant Server). There 
have been no reports of individuals homozygous for the frameshift variant in dbSNP, 
1000 Genomes, and ExAC Browser. However, we argue that due to the mild pheno-
type, some affected individuals can easily go undiagnosed.  
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In order to verify that mutations in SERPINB8 underlie the exfoliative ichthyosis, 10 
individuals with similar clinical pictures were screened for SERPINB8 mutations us-
ing Sanger sequencing. Exon/intron boundaries of SERPINB8 were amplified by 
PCR using primers designed with Primer3 Software (version 0.4.0). Primer sequenc-
es are listed in Supplemental Table S1. DNA sequencing was done using BigDye 
terminator master mix (Thermofisher) and generated sequences were aligned and 
compared with the reference sequence from NCBI Entrez Nucleotide database 
(transcript NM_198833) using the web-based program MultAlin. A homozygous mis-
sense mutation in SERPINB8, exon 2: c.2T>C; p.Met1? was identified in the affected 
individual of family two (Figure 1H). The mother was heterozygous for the missense 
mutation. No DNA was available from the father to perform carrier testing. The muta-
tion was predicted to be probably damaging by PolyPhen-2 with a score of 1 and 
disease-causing by Mutation Taster with a score of 1. It affects the start codon of the 
longest SERPINB8 transcript (isoform a, NM_198833.1) and interferes with initiation 
of translation, putatively giving rise to an N-terminal truncated SERPINB8. NCBI 
ORF Finder software identified an alternative in-frame start codon, 33 codons down-
stream of the initial start codon. Moreover, a shorter isoform c of SERPINB8 exists 
(NM_001276490.1), which uses an alternate splice junction in the 5' UTR and lacks 
the first exon containing the translation start site compared to isoform a and, there-
fore, translation of isoform c is not affected.  
Subsequently, exome sequencing in II-6 and I-2 individuals of a large Israeli family 
was performed (family three) (Figure 1G). Genomic DNA was extracted from periph-
eral blood leukocytes using the 5 Prime ArchivePure DNA Blood Kit (5 Prime Inc.). 
Exome sequencing was performed by BGI Tech Solutions Ltd. Whole-exome cap-
ture was carried out by in-solution hybridization with SureSelect All Exon 51Mb Ver-
 
7 
 
sion 4.0 (Agilent) followed by massively parallel sequencing (Illumina HiSeq2000) 
with 100-bp paired-end reads. Reads were aligned to the Genome Reference Con-
sortium Human Build 37 (GRCh37/hg19) using Burrows-Wheeler Aligner.11 Duplicate 
reads, resulting from PCR clonality or optical duplicates, and reads mapping to mul-
tiple locations were excluded from downstream analysis. Reads mapping to a region 
of known or detected insertions or deletions were re-aligned to minimize alignment 
errors. Single-nucleotide substitutions and small insertion deletions were identified 
and quality filtered using the Genome Analysis Tool Kit.12 Rare variants were identi-
fied by filtering using the data from dbSNP138, the 1000 Genomes Project, the Ex-
ome Variant Server, and an in-house database of sequenced individuals. Variants 
were classified by predicted protein effects using PolyPhen-2 and SIFT.13; 14 The 
homozygous nonsense mutation c.850C>T, p.Arg284* in exon 7 in SERPINB8 was 
identified in individual II-6 (Figure 1G, 1H). His mother was heterozygous carrier of 
the mutation. Sanger sequencing was performed in all other available family mem-
bers. Both affected siblings, II-7 and II-8, were also found to be homozygous for 
p.Arg284*. The father was confirmed to be heterozygous carrier of the mutation to-
gether with four healthy siblings (Figure 1G). A skin biopsy was obtained from indi-
vidual II-6 of family three and H&E staining revealed acanthosis, hyperkeratosis, and 
disadhesion of keratinocytes in the basal and suprabasal layers of the epidermis with 
evidence of intercellular space widening (Figure 2A, 2B). In addition, indirect immu-
nofluorescence analysis was performed in paraffin-embedded sections of palmar 
skin of individual II-6 and compared to a matched control. Localization of SERPINB8 
was assessed using the monoclonal anti-SERPINB8 antibody (Santa Cruz sc-
101371), which showed a cytoplasmic and nuclear distribution mainly in the su-
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prabasal and granular layers of control skin (Figure 2C). SERPINB8 was strongly 
reduced in the proband’s skin (Figure 2D). 
In order to further characterize the loss of SERPINB8 in keratinocytes, we utilized a 
siRNA pool to knockdown SERPINB8 in the HaCaT human keratinocyte cell line. 
ON-TARGETplus SMART-pool siRNA (Dharmacon) was used to knock down SER-
PINB8 in the HaCaT cells. Control keratinocytes were treated with a non-targeting 
pool (NTP) (Dharmacon). 72 hours after transfection, the efficiency of the knockdown 
was validated by immunoblotting with a primary antibody against SERPINB8 (Santa 
Cruz) (Figure 3A). As the symptoms in all affected individuals mainly occurred on 
sites exposed to high mechanical trauma, we first studied the effect of mechanical 
stress on keratinocytes by means of a dispase-based dissociation assay. In this as-
say, relative changes in epithelial cohesion were monitored by comparing the num-
ber of fragments in control and knockdown (KD) cells after treatment with dispase. 
Cystatin A (CSTA)-KD cells were used as positive control as we have previously 
shown that loss of this protease inhibitor impairs cell-cell adhesion.7  The dispase-
based dissociation assay was performed as described elsewhere.15 In brief, 72 hours 
after transfection of HaCaT cells with NTP, CSTA siRNA or SERPINB8 siRNA, con-
fluent cell monolayers were treated with 700 µl of 5 mg/ml dispase for approximately 
30 minutes at 37°C until the monolayers were detached completely. Released mono-
layers were washed twice in 500µl PBS, transferred to 2 ml tubes, and subjected to 
50 inversion cycles. The fragments were counted under an inverted microscope. 
Similar to CSTA, SERPINB8-KD cells showed an increased number of fragments 
compared to the NTP control cells, indicating that cell-cell adhesion is impaired in 
both CSTA-KD and SERPINB8-KD cells (Figure 3B). Since the desmosomes repre-
sent one of the major intercellular adhesive junctions in the epidermis, we assessed 
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the protein levels of two desmosomal molecules, desmoplakin (DP-1, Progen) and 
desmoglein-1 (clone MCA2271, Bio-Rad AbD). Immunoblotting showed an upregula-
tion of both desmosomal proteins in the SERPINB8-KD cells, compared to NTP con-
trol cells (Figure 3C). In addition, keratinocyte monolayers were exposed to oscillat-
ing mechanical stress using the Flexcell FX-4000 tension system (Flexcell Interna-
tional). The stretching assay was performed as described previously.7 In brief, Ha-
CaT cells were seeded on BioFlex 6-well plates coated with pronectin (Flexcell Inter-
national). 72 hours after transfection of HaCaT cells with NTP or SERPINB8 siRNA, 
monolayers were subjected to cyclic mechanical stress for four hours with a frequen-
cy of 5 Hz and an elongation of amplitude ranging from 10 – 13 %. A FlexStop™ 
valved rubber stopper was used to prevent control (non-stretched, 0h) cells from be-
ing exposed to mechanical loads. The efficiency of the KD of SERPINB8 was vali-
dated by immunoblotting and quantitative real-time PCR (qPCR) (Supplemental Fig-
ure S1). No morphological changes were observed, but indirect immunofluorescence 
staining revealed increased levels of desmoplakin (DP-1, Progen) along the plasma 
membrane in both stretched and non-stretched SERPINB8-KD keratinocytes, with 
stretched SERPINB8-KD cells showing a more striking increase in desmoplakin lev-
els, compared to NTP control cells (Figure 3C). Moreover, the desmoplakin staining 
pattern showed evidence of a shift from a plasma membranous localization in NTP 
control cells to increased cytoplasmic localization in SERPINB8-KD cells (Figure 
3C). qPCR data shows that the mRNA levels of desmoplakin isoforms I and II and 
desmoglein-1 were decreased in SERPINB8-KD cells indicating that the increased 
protein levels observed for these desmosomal proteins is not due to an upregulation 
of mRNA transcription (Supplemental Figure S1), but instead may be due to an in-
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crease in protein stabilization. Further studies are required to uncover the mecha-
nisms by which these proteins are upregulated.   
SERPINS comprise the largest group of protease inhibitors known to date. Despite 
their functional versatility, all SERPINS contain a highly conserved surface-exposed 
reactive site loop (RSL), which interacts with the target protease to form tight, irre-
versible complexes. 9; 16 In addition, SERPINB8 contains two hydrophobic regions in 
close proximity to the N-terminus (Figure 1H), which are thought to be important for 
secretion of SERPINB8, consequently, SERPINB8 can either reside intracellularly or 
extracellularly.17; 18 In paraffin embedded skin sections, SERPINB8 localizes mainly 
to the cytoplasm, however the exact epitope to which the antibody binds is unknown. 
SERPINB8 signals were strongly reduced in the individuals’s skin homozygous for 
c.850C>T, p.Arg284*. As the nonsense mutation is located in the last exon of SER-
PINB8, we predict that the transcript will not be subjected to nonsense-mediated 
mRNA decay, but rather the mutation results in a C-terminally truncated protein. 
Therefore, the reduced protein levels in the loss-of-function skin suggest that the 
mutant SERPINB8 with the alternative C-terminal end is less stable than the wildtype 
protein. Since we have no access to material from affected individuals of families 
one and two, we predict the following for the mutations disclosed in those individuals: 
For the missense variant identified in family two, c.2T>C; p.Met1?, which affects the 
start codon of SERPINB8, we postulate the expression of a truncated version of iso-
form a and full-length isoform c in the affected individual’s skin that both lack the two 
hydrophobic regions and thus, the ability to be transported outside of the cell. As an 
additional start codons is present upstream of the RSL, it will most likely be unaffect-
ed, and SERPINB8 is predicted to retain its ability to act as an intracellular protease 
inhibitor. In contrast, in the frameshift variant, c.947delA; p.Lys316Serfs*90, identi-
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fied in the two Tunisian siblings of family one, the hydrophobic regions will be pre-
served, but the RSL will be fully absent, and the inhibiting properties of SERPINB8 
inside and outside the cell will be completely lost. Even though the type and location 
of mutations differ in the affected individuals, we predict that all three variants cause 
SERPINB8 to lose its ability to act extracellularly. This suggests that SERPINB8 
plays an important role in regulating extracellular protease cascades in skin. In vitro 
studies have previously found that soluble recombinant furin can be inhibited by 
SERPINB8, presumably by entering the secretory pathway.18  
Furthermore, we characterized SERPINB8 in skin and HaCaT human keratinocytes 
and performed in vitro studies utilizing siRNA-mediated knockdown of SERPINB8 in 
keratinocytes. In the absence of SERPINB8 in keratinocytes, there is a cell-cell ad-
hesion defect, particularly when cells are subjected to mechanical stress, alongside 
a dysregulation of the desmosomal proteins, desmoplakin and desmoglein-1. A 
dysregulation of desmosomal proteins was also reported for the two protease inhibi-
tors, Cystatin A (CSTA [MIM: 184600]) and calpastatin (CAST [MIM: 114090]), that 
we have recently implicated in the pathogenesis of peeling skin conditions.7; 8 These 
similar morphological features associated with loss-of-function mutations in CSTA 
and CAST are reflected in some overlap in clinical presentation to individuals harbor-
ing homozygous loss-of-function SERPINB8 mutations. Clinical manifestations relat-
ed to CSTA mutations include palmoplantar keratoderma and superficial exfoliation 
of the skin (MIM: 607936) whereas mutations in CAST underlie generalized skin 
peeling with underlying erythema, blistering, leukonychia, plantar keratosis, cheilitis, 
and knuckle pads (MIM: 616295).7; 8  
Interestingly, mutations in SERPINB7 have recently been identified to cause Na-
gashima-type palmoplantar keratosis.3 This study specifically identified the founder 
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mutation, c.796C>T; p.Arg266* (NM_001040147.2) in the Japanese and Chinese 
populations, leading to complete loss of the inhibitory activity of SERPINB7 and sig-
nificant reduction in protein levels in the lesional skin compared to the control, where 
SERPINB7 was located to the cytoplasm of the granular and cornified layer. Similar 
to SERPINB8, SERPINB7 related clinical features are confined to distal extremities, 
particularly on palms and soles, and suggests that both SERPINS are prominent at 
sites exposed to increased mechanical forces, controlling stress-induced protease 
cascades.3 Even though in vitro studies have recently identified several target prote-
ases, including furin, trypsin, and thrombin, the true physiological targets of SER-
PINB8 in the skin are still unknown. However, other SERPINS, including SERPINB3, 
SERPINB4 and SERPINB6 that are known to be active in the epidermis do not only 
effectively inhibit serine proteases, including kallikrein-8 and cathepsin G, but are 
also capable of inhibiting cysteine proteases like Cathepsin L, Cathepsin K or Ca-
thepsin S.2 Together with furin, cathepsins and kallikreins represent the most likely 
target substrates for SERPINB8 in skin, as they regulate different stages of keratino-
cyte differentiation in the epidermis, including cornified envelope formation and des-
quamation2 and were also shown to be involved in the processing of desmosomal 
adhesion molecules.6; 19; 20   
In conclusion, we describe mutations in SERPINB8 that are associated with autoso-
mal recessive exfoliative ichthyosis and we provide evidence that SERPINB8 con-
tributes to the mechanical stability of intercellular adhesions in the epidermis. Addi-
tional functional assays will be required to investigate the precise physiological role 
of SERPINB8 and to unravel its target proteases in the skin. 
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FIGURE LEGENDS 
 
 
Figure 1: Clinical features, pedigrees, and SERPINB8 mutations of individuals 
with autosomal recessive exfoliative ichthyosis  
(A) Individual II-2 from family one showed superficial peeling of small areas of his 
palmar surfaces, with an underlying erythema. (B) The only affected individual of 
family two presented with a mild peeling on her forearms. (C,D) Diffuse yellowish 
hyperkeratotic plaques over the palms and soles of individuals II-7 (C) and II-8 (D) of 
family three. (E) Individual II-8 of family three displayed superficial white scale with 
no significant erythema over her lower extremities. (F,G) Pedigrees and genotypes 
of families one and three. The homozygous frameshift variant, c.947delA; 
p.Lys316Serfs*90 was identified in individuals II-2 and II-5 of family one, who were 
born to consanguineous parents (F). The homozygous nonsense mutation 
c.850C>T, p.Arg284* in SERPINB8 was identified in individuals II-6, II-7, and II-8 of 
family three (G). (H) Schematic representation of SERPINB8 and its domains. SER-
PINB8 contains two hydrophobic regions (H1 and H2), which are thought to be im-
portant for secretion of the protein, and a reactive site loop (RSL), which is crucial for 
its interaction with target substrates. The mutations are indicated in red. The variant 
p.Met1? affects the start codon, predicted to result in an N-terminal truncated protein 
lacking both hydrophobic regions. p.Lys316Serfs*90 and p.Arg284* are located a 
few amino acids upstream of the RSL and are predicted to lead to loss of the RSL.   
 
Figure 2: Morphological analysis of  SERPINB8 loss-of-function skin  
(A,B) Skin biopsies obtained from individual II-6 of family three demonstrated acan-
thosis, hyperkeratosis, and disadhesion of keratinocytes in the basal and suprabasal 
layers of the epidermis with evidence of intercellular space widening. (hematoxylin 
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and eosin; bars = A 100µm; B 40µm). (C,D) Indirect immunfluorescence analysis of 
SERPINB8 in control and SERPINB8 loss-of-function skin. The monoclonal anti-
SERPINB8 antibody (Santa Cruz sc-101371) showed a cytoplasmic and nuclear dis-
tribution of the protease inhibitor in the suprabasal and granular layers in control skin 
(C). SERPINB8 signals were strongly reduced in the skin of the individual homozy-
gous for p.Arg284* (D). Bar = 200µm. 
 
Figure 3: Knockdown (KD) of SERPINB8 affects cell-cell adhesion in vitro 
(A)  A siRNA pool was utilized to knockdown SERPINB8 in HaCaT cells. SERPINB8 
protein levels were compared to control cells treated with a non-targeting pool (NTP) 
and was validated by immunoblotting (*** p ≤ 0.001). (B) A dispase-based dissocia-
tion assay was performed to assess intercellular adhesion by the degree of cell 
monolayer integrity upon mechanical stress. Similar to Cystatin A (CSTA)-KD, SER-
PINB8-KD cells showed an increased number of fragments compared to NTP control 
cells (** p ≤ 0.01). Bar = 50 µm (C) Immunoblotting of cell lysates from SERPINB8-
KD cells showed an upregulation of both desmoplakin isoforms I and II as well as 
increased levels of desmoglein-1, as compared to NTP control cells. Likewise, im-
munostaining revealed a strong upregulation of desmoplakin in SERPINB8-KD cells. 
Upon stretching of SERPINB8-KD monolayers for four hours, desmoplakin levels 
were even more prominent in the SERPINB8-KD cells. Bar = 40 µm. 
 
 
18 
 
 
 
 
 
19 
 
 
 
 
 
 
 
 
20 
 
 
